Aparna A Wagle Shukla

Aparna A Wagle Shukla, M.D.

Associate Professor, Director Of Clinical Trials

Department: MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone: (352) 273-5550

About Aparna A Wagle Shukla

Dr. Wagle Shukla is an Associate Professor in the movement disorders division of the Department of Neurology at the University of Florida. Dr. Wagle Shukla received training in movement disorders from the University of Toronto, Canada and has been a faculty at the University of Florida for the last ten years.

Dr. Wagle Shukla’s goal of practice is to provide the highest level of quality care to patients with Parkinson’s disease, dystonia, tremors, chorea, and many other movement disorders. She is experienced and proficient in the administration of botulinum toxin for dystonia, sialorrhea, migraines, and spasticity. The University of Florida is world renowned for deep brain stimulation (DBS) surgery. DBS is a highly effective treatment for patients with Parkinson’s disease, essential tremor, dystonia, Tourette syndrome, and Obsessive Compulsive Disorder. She plays an active role in the DBS program at the University of Florida. She provides expertise for microelectrode recording during DBS surgeries for accurate placement of the electrode in the brain. She also provides outpatient care for these patients through DBS programming.

Board Certifications

  • Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Neurology
Areas of Interest
  • Dystonia
  • Movement – uncontrollable
  • Parkinson disease
  • Sydenham chorea
  • Tourette syndrome
  • Tremor

Research Profile

Dr. Wagle Shukla is committed to research in movement disorders in many ways. She is the director for transcranial magnetic stimulation (TMS) Laboratory and the co-director for clinical trials in essential tremor, dystonia, Parkinson’s disease, Huntington’s disease and Tourette syndrome to develop better treatments for these conditions. Dr. Wagle Shukla has been appointed as the Director for the Neurophysiology core research lab at the Fixel Institute for Neurological Diseases. The mission of the core lab is to advance the electrophysiological understanding of tremors, dystonia, myoclonus, and psychogenic movement disorders. She is the clinical director for Tyler’s Hope Foundation for Dystonia and a member of Tremor Research Group.

Dr. Wagle Shukla is working on many projects to elucidate the mechanisms underlying dystonia, dystonia treatments and develop novel treatments for dystonia, particularly involving the use of noninvasive repetitive TMS in conjunction with oral pharmacological therapies, botulinum toxin injections, and DBS surgery. She is working on increasing the applications of rehabilitation therapies in the field of movement disorders. Similarly, Dr. Wagle Shukla is also working on many tremor disorders, including essential tremor, Parkinson’s disease, dystonic tremor, and orthostatic tremor. She has been awarded numerous grants for this research through the Dystonia Coalition, Dystonia Medical Research Foundation, CTSI at UF (National Institute of Health sponsored KL2 grant), Brain and Spinal Cord Injury Research Trust Fund, Blepharospasm Research Foundation, National Organization for Rare Disorders and the National Institute of Health (NINDS K23 Grant). She has made several international presentations on her research and has more than 70 publications in many prestigious peer-reviewed journals including, Brain, Neurology, Journal of Neurology and Neurosurgery and Movement Disorders.

Open Researcher and Contributor ID (ORCID)

0000-0002-9757-9973

Publications

2016 Movement Disorders Clinical Practice
2015 Journal of Clinical and Experimental Neuropsychology

Grants

Jul 2016 – Sep 2018
Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia
DYSTONIA MEDICAL RES FOU · Mentor
Jul 2016 ACTIVE
Functional Brain networks in essential Tremor and
NATL INST OF HLTH NINDS · Principal Investigator
Aug 2015 – Nov 2015
A 12 Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT 301 (Levodopa Inhalation Powder) in Parkinsons Disease Patients With Motor Response Fluctuations (OFF Phenomena)
CIVITAS THERAPEUTICS INC · Principal Investigator
Jul 2015 – Jun 2017
ABF Fellowship
AMER ACAD OF NEUROLOGY · Principal Investigator
Mar 2015 – Nov 2018
rTMS therapy
National Organization for Rare Disorders · Principal Investigator
Jan 2015 – Apr 2017
Combined effects of rTMS and botulinum toxin in benign e
Benign Essential Blepharospasm Res Fou · Principal Investigator
Jul 2014 – Jun 2016
UFF Companion to ABF Fellowship
UF FOU · Principal Investigator
Jun 2013 – Feb 2016
A PHASE IIIb, prospective, MULTICENTRE, open-label EXTENSION STUDY TO ASSESS LONG TERM SAFETY AND EFFECTIVENESS OF DYSPORT
IPSEN BIOPHARMACEUTICALS · Principal Investigator
May 2013 – Feb 2016
DYSPORT 169
IPSEN BIOPHARMACEUTICALS · Principal Investigator
Nov 2011 – Oct 2016
MASTER PD-Cost Share
UF FOU · Principal Investigator
Jul 2006 ACTIVE
BRAIN AND SPINAL CORD INJURY RESEARCH
FL DEPT OF HLTH · Project Manager

Education

Residency – Neurology
2006-2010 · University of Arkansas
Fellowship
2003-2006 · University of Toronto
Medical School
1996 · NHL MMC, India

Contact Details

Phones:
Business:
(352) 273-5550